EBT-107 (Excision BioTherapeutics)

N/A

Report date: 2025/08/20 16:52:43

Base Information

Drug NameEBT-107 (Excision BioTherapeutics)
Drug Alias NameEBT-107 (Excision BioTherapeutics)
ClassificationSmall molecules > LipidCell and gene therapy > Gene therapy > Gene editing > CRISPR
Mechanisms of ActionHepatitis B virus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesExcision BioTherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesExcision BioTherapeutics Inc
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A